Low FODMAPs Diet in Gastrointestinal Disorders
Launched by FEDERICO II UNIVERSITY · Aug 22, 2018
Trial Information
Current as of August 31, 2025
Completed
Keywords
ClinConnect Summary
Recurrent gastrointestinal symptoms (bloating, constipation, abdominal pain, diarrhea and flatulence) often interfere with patients' quality of life (QoL) and daily activities. These symptoms have been noted in various diseases such as irritable bowel syndrome (IBS), celiac disease (CD) and inflammatory bowel diseases (IBD). IBS is the most common diagnosis made by gastroenterologists and affects up to 15% of the population. About 60% of patients with IBS claims that certain foods can exacerbate their symptoms, so pharmacological treatment is often accompanied by dietary measures. Very rece...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • IBS patients
- • IBD patients in remission
- • Coeliac patients on gluten free diet
- Exclusion Criteria:
- • Active IBD
- • Coeliac patients non compliant to gluten free diet
About Federico Ii University
Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Naples, , Italy
Patients applied
Trial Officials
Fabiana Castiglione
Principal Investigator
Federico II University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials